Computational Docking and Pharmacological Evaluation of Natural Alkaloids as Safer Alternatives to Synthetic Narcotics

The increasing prevalence of opioid misuse and associated fatalities has highlighted an urgent need for safer analgesic alternatives. Synthetic narcotics such as morphine and fentanyl remain highly effective in clinical pain management but are associated with significant risks, including tolerance, dependence, and respiratory depression (Volkow et al., 2019). Natural alkaloids, derived from medicinal plants, possess diverse pharmacological properties and may provide novel therapeutic approaches with reduced abuse liability. In this study, computational docking and in silico pharmacological evaluations were performed on selected natural alkaloids—mitragynine, berberine, conolidine, noscapine, and papaverine—against μ-opioid (MOR), κ-opioid (KOR), and δ-opioid (DOR) receptors. Docking affinities and receptor-ligand interactions were compared to synthetic narcotics, including morphine, fentanyl, and oxycodone. Additionally, ADMET (absorption, distribution, metabolism, excretion, and toxicity) predictions were conducted to evaluate safety and drug-likeness. Results demonstrated that several alkaloids, particularly mitragynine and conolidine, exhibited strong receptor affinity with favorable pharmacokinetic properties. These findings support the hypothesis that natural alkaloids may serve as promising analgesic candidates, warranting further preclinical and clinical investigation.